P3.01-48 the Efficiency of Low-Dose Apatinib in Treatment of Advanced Lung Squamous Cell Carcinoma

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1608
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

P3.01-49 Effciency of Low-Dosage Apatinib Monotherapy in Treatment of Advanced Lung Squamous Cell Carcinoma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P3.01-16 Low Dose Apatinib Combined With EGFR-TKI in Treating Advanced NSCLC After First-Generation EGFR-TKIs Treatment Failure

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Long-Term Progression-Free Survival of Third-Line Apatinib in Lung Squamous Cell Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2018English

Medical Treatment of Advanced Cutaneous Squamous‐cell Carcinoma

Journal of the European Academy of Dermatology and Venereology
DermatologyInfectious Diseases
2019English

Clinical Efficacy and Safety of Apatinib Combined With S-1 in Advanced Esophageal Squamous Cell Carcinoma

Investigational New Drugs
OncologyPharmacology
2019English

Advanced Squamous Cell Carcinoma of the Larynx

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
1990English

P2.01-017 Study on the Effect of Apatinib Salvage Treatment of Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2017English

Treatment Approaches in Immunosuppressed Patients With Advanced Cutaneous Squamous Cell Carcinoma

Journal of the European Academy of Dermatology and Venereology
DermatologyInfectious Diseases
2019English

Surgical Treatment Is Recommended for Advanced Oral Squamous Cell Carcinoma

Tohoku Journal of Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy